T-box2 (TBX2) expression has been reported to be related to aggressive tumor features. However, the role of TBX2 in non-small-cell lung cancer (NSCLC) tumorigenesis has never been elucidated. So we aimed at investigating the potential role of TBX2 in NSCLC. TBX2 expression was evaluated by qRT-PCR and Western blotting in 50 paired fresh lung cancer tissues as well as immunohistochemistry on 212 paraffin-embedded sections. We showed that the expression level of TBX2 was significantly increased in NSCLC as compared with the adjacent noncancerous tissue. Positive expression level of TBX2 was associated with histological type, lymph node metastasis and distant metastasis. Kaplan–Meier survival curves showed that positive expression level of TBX2 was associated with poor overall survival (OS) and progression-free survival of NSCLC patients. Results showed that TBX2 positivity was an independent prognostic factor for OS (HR 1.87, 95 % CI 1.004–3.153, p = 0.012). On the basis of these results, we suggested that TBX2 protein expression may be an unfavorable independent prognostic parameter for NSCLC.
Non-small cell lung cancer TBX2 Prognosis
This is a preview of subscription content, log in to check access.
This work was supported by a grant from the development project of medical science and technology of Shandong Province (2013WS0107).
Conflict of interest
Abrahams A, Parker MI, Prince S (2010) The T-box transcription factor Tbx2: its role in development and possible implication in cancer. IUBMB Life 62:92–102PubMedGoogle Scholar
Barlund M, Monni O, Kononen J et al (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 60:5340–5344PubMedGoogle Scholar
Chen D, Zhang Y, Zhang X et al (2013) Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes. Acta Histochem 115:128–136PubMedCrossRefGoogle Scholar
Filipits M, Pirker R (2011) Predictive markers in the adjuvant therapy of non-small cell lung cancer. Lung Cancer 74:355–363PubMedCrossRefGoogle Scholar
Jacobs JJ, Keblusek P, Robanus-Maandag E et al (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 26:291–299PubMedCrossRefGoogle Scholar
Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 32:71–96CrossRefGoogle Scholar
Kandimalla R, van Tilborg AA, Kompier LC et al (2012) Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers. Eur Urol 61:1245–1256PubMedCrossRefGoogle Scholar
Mahlamaki EH, Barlund M, Tanner M et al (2002) Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35:353–358PubMedCrossRefGoogle Scholar
Prince S, Carreira S, Vance KW, Abrahams A, Goding CR (2004) Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res 64:1669–1674PubMedCrossRefGoogle Scholar
Tsim S, O’Dowd CA, Milroy R, Davidson S (2010) Staging of non-small cell lung cancer (NSCLC): a review. Respir Med 104:1767–1774PubMedCrossRefGoogle Scholar
Tsuchiya T, Akamine S, Muraoka M et al (2007) Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 56:341–348PubMedCrossRefGoogle Scholar
Vance KW, Carreira S, Brosch G, Goding CR (2005) Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res 65:2260–2268PubMedCrossRefGoogle Scholar
Zhang J, Ning J, Geng J, Cui B, Dong X (2012) Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer. J Mol Histol 43:715–721PubMedCrossRefGoogle Scholar